Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6601 AL 6615

Huntington's Disease and Psychiatric Comorbidities: A Retrospective Study in Portugal

Rocha J, Soares C, Gonçalves-Pinho M.

Acta Med Port. 2025 Nov 3;38(11):689-698. doi: 10.20344/amp.23438. Epub 2025 Nov 3.

Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options

Ceraolo G, Spoto G, Consoli C, Modafferi E, Di Rosa G, Nicotera AG.

Life (Basel). 2025 Jun 20;15(7):992. doi: 10.3390/life15070992.

Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington's disease

Pradhan S, Gaikwad S, Tsai CL, Smith C, Zhang N, Bush K, Chakraborty A, Yuan S, Choudhary S, Keene CD, Ellerby LM, Hazra TK, La Spada AR, Wairkar YP, Ashizawa T, Tainer JA, Pandita TK, Thompson LM, Sarkar PS.

bioRxiv [Preprint]. 2025 Jul 24:2025.07.24.666629. doi: 10.1101/2025.07.24.666629.

BDNF/proBDNF Interplay in the Mediation of Neuronal Apoptotic Mechanisms in Neurodegenerative Diseases

Mitrovic M, Selakovic D, Jovicic N, Ljujic B, Rosic G.

Int J Mol Sci. 2025 May 21;26(10):4926. doi: 10.3390/ijms26104926.

Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis

Nakatsuka N, Adler D, Jiang L, Hartman A, Cheng E, Klann E, Satija R.

Nat Commun. 2025 Aug 12;16(1):7436. doi: 10.1038/s41467-025-62579-z.

[Bruxism and neurodegenerative diseases, is there a connection?]

Kurpez T, Verhoeff M C, Thymi M, de Vries R, Lobbezoo F.

Ned Tijdschr Tandheelkd. 2025 May 6;132(5):274-279. doi: 10.5177/ntvt.2025.05.25009.

Sleep in neurodegenerative diseases: A focus on melatonin, melanin-concentrating hormone and orexin

Guillot SJ, Luppi PH, Dupuis L, Bolborea M.

J Neuroendocrinol. 2025 Nov;37(11):e70085. doi: 10.1111/jne.70085. Epub 2025 Aug 31.

The Digital Frontier in Huntington's Disease: Opportunities for Clinical Trials

Quinn L, Roché MW, Dorn J, Adams JL.

Mov Disord. 2025 Oct;40(10):2067-2076. doi: 10.1002/mds.30277. Epub 2025 Jul 14.

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases

Denaro S, D'Aprile S, Vicario N, Parenti R.

Front Cell Neurosci. 2025 Feb 11;19:1532960. doi: 10.3389/fncel.2025.1532960. eCollection 2025.

Lipid Droplet in Lipodystrophy and Neurodegeneration

Behera P, Mishra M.

Biol Cell. 2025 Apr;117(4):e70009. doi: 10.1111/boc.70009.

Time-restricted eating in early-stage Huntington's disease: A 12-week interventional clinical trial protocol

Wells RG, Neilson LE, McHill AW, Hiller AL.

PLoS One. 2025 Mar 25;20(3):e0319253. doi: 10.1371/journal.pone.0319253. eCollection 2025.

A new hope for patients with Huntington's disease?

eClinicalMedicine.

EClinicalMedicine. 2025 Oct 23;88:103612. doi: 10.1016/j.eclinm.2025.103612. eCollection 2025 Oct.

DNA extrusion size determines pathway choice during CAG repeat expansion

Bhatia M, Phadte AS, Lakhina A, Monte Carlo AR, Barndt S, Pluciennik A.

bioRxiv [Preprint]. 2025 May 15:2025.05.12.653571. doi: 10.1101/2025.05.12.653571.

Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington's Disease

Zhang X, Zhang S, Wang C.

Int J Mol Sci. 2025 Nov 11;26(22):10907. doi: 10.3390/ijms262210907.

The Role of the human microbiome in neurodegenerative diseases: A Perspective

Mukherjea N, Khandelwal A, Saluja R, Kalra N.

Curr Genet. 2025 Aug 21;71(1):17. doi: 10.1007/s00294-025-01319-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias